Try it
Pharmacology · Lipid drugs: fibrates
Sample itemA patient with severe hypertriglyceridaemia and recurrent pancreatitis is started on fenofibrate. Through which receptor does it act?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. PPAR-alpha, increasing lipoprotein lipase activity and fatty acid oxidation
Fibrates activate PPAR-alpha, increasing lipoprotein lipase and lowering VLDL and triglycerides, while raising HDL modestly. Adverse effects include gallstones, myopathy (especially with statins) and potentiation of warfarin.
Option by option
A. PPAR-gamma
PPAR-gamma is the target of glitazones.
B. NPC1L1
NPC1L1 is the target of ezetimibe.
C. PPAR-alpha, increasing lipoprotein lipase activity and fatty acid oxidation (correct)
Correct. PPAR-alpha is the fibrate target.
D. LDL receptor directly
LDL receptors are not directly activated by fibrates.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?